Sunshine Biopharma Files Q1 2025 10-Q
Ticker: SBFMW · Form: 10-Q · Filed: May 15, 2025 · CIK: 1402328
| Field | Detail |
|---|---|
| Company | Sunshine Biopharma Inc. (SBFMW) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
Sunshine Biopharma's Q1 2025 10-Q is in. Check financials for common stock, preferred stock, and warrants.
AI Summary
Sunshine Biopharma Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information for the first quarter of 2025, including balances for common stock, preferred stock, and warrants. The company's principal executive offices are located at 333 Las Olas Way, Fort Lauderdale, FL.
Why It Matters
This filing provides investors with an update on Sunshine Biopharma's financial position and performance for the first quarter of 2025, crucial for understanding the company's ongoing operations and potential.
Risk Assessment
Risk Level: medium — As a 10-Q filing, it contains detailed financial information which can be complex and may indicate potential risks or opportunities for investors.
Key Numbers
- 2025-03-31 — Reporting Period End Date (Indicates the end of the financial quarter being reported.)
- 2025-05-15 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
- 2024-12-31 — Previous Year End Date (Provides a comparison point for financial performance and position.)
Key Players & Entities
- Sunshine Biopharma Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250515 (date) — Filing date
- 333 Las Olas Way, Fort Lauderdale, FL (location) — Company's business and mailing address
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is for the quarter ended March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 15, 2025.
What is Sunshine Biopharma Inc.'s principal business address?
Sunshine Biopharma Inc.'s principal business address is 333 Las Olas Way, CU4 Suite 433, Fort Lauderdale, FL 33301.
What financial elements are specifically mentioned in relation to the reporting period?
The filing mentions financial elements such as Common Stock, Warrant, Series B Preferred Stock, Additional Paid In Capital, Preferred Stock, Comprehensive Income, and Retained Earnings for various periods including March 31, 2025, December 31, 2024, and March 31, 2024.
What is the Standard Industrial Classification (SIC) code for Sunshine Biopharma Inc.?
The SIC code for Sunshine Biopharma Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Sunshine Biopharma Inc. (SBFMW).